| Milan Stock Exchange: REC
Recordati SpA manufactures and markets pharmaceutical products. It operates through the Pharmaceutical and Orphan Drugs segments. The Pharmaceutical segment includes the sale of pharmaceutical products and operations of pharmaceutical chemicals. The Orphan Drugs segment develops and provides drugs for the treatment of rare diseases. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.